抄録
A “Drug information brochure for inpatients undergoing CHOP therapy” was prepared in order to minimize inter-individual difference in pharmaceutical care and drug consultation by clinical pharmacists and to ensure the accurate understanding of the patients. The CHOP regimen has been conducted as the standard method for the treatment of non-Hodgikin's lymphoma. The draft version of the brochure was prepared based on information provided by the pharmaceutical companies and from the literature in advance, and the brochure was revised after the drug consultations by clinical pharmacists, especially through the monitoring of any adverse events. The revisions included the time period when adverse events might be encountered ; and the methods to help the patients cope with such adverse events, the initial symptoms of such adverse events, and other potential problems. By using this brochure, clinical pharmacists could conduct the drug consultation more effectively and accurately while also ensuring that patients obtained a maximum understanding of the CHOP therapy regimen.
